Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.03B P/E - EPS this Y 225.70% Ern Qtrly Grth -
Income 10.13M Forward P/E 12.12 EPS next Y -3.80% 50D Avg Chg 1.00%
Sales 449.39M PEG 5.13 EPS past 5Y -10.88% 200D Avg Chg 19.00%
Dividend N/A Price/Book 2.69 EPS next 5Y 2.20% 52W High Chg -6.00%
Recommedations 1.70 Quick Ratio 2.77 Shares Outstanding 20.43M 52W Low Chg 67.00%
Insider Own 12.14% ROA 3.11% Shares Float 14.78M Beta 0.89
Inst Own 66.13% ROE 3.38% Shares Shorted/Prior 376.80K/415.40K Price 51.13
Gross Margin 62.23% Profit Margin 2.98% Avg. Volume 142,772 Target Price 71.67
Oper. Margin 11.68% Earnings Date Nov 8 Volume 67,516 Change 0.69%
About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

ANI Pharmaceuticals, Inc. News
11/22/23 ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
11/19/23 A Boring Biopharma Can Be a Good Bet
11/17/23 Insider Sell Alert: SVP, CHIEF HR OFFICER Krista Davis Sells Shares of ANI Pharmaceuticals Inc
11/10/23 Is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock Price Struggling As A Result Of Its Mixed Financials?
11/09/23 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q3 2023 Earnings Call Transcript
11/08/23 ANI Pharmaceuticals Inc (ANIP) Reports Record Q3 2023 Results; Raises Full-Year Guidance
11/08/23 Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics
11/08/23 ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
11/02/23 Poseida Therapeutics, Inc. (PSTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11/01/23 ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note
11/01/23 ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
10/30/23 ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences
10/25/23 ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET
10/20/23 ANI Pharmaceuticals (ANIP) Increases Despite Market Slip: Here's What You Need to Know
10/19/23 ANI Pharmaceuticals (ANIP) Stock Moves -0.14%: What You Should Know
10/13/23 ANI Pharmaceuticals (ANIP) Stock Moves -0.48%: What You Should Know
10/06/23 ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why
10/05/23 (ANIP) Advances While Market Declines: Some Information for Investors
10/02/23 ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares
09/29/23 ANI Pharmaceuticals (ANIP) Dips More Than Broader Markets: What You Should Know
ANIP Chatroom

User Image cctranscripts Posted - 1 day ago

Muthusamy Shanmugam just provided an update on activist position in ANI Pharmaceuticals https://www.conferencecalltranscripts.org/summary/?id=12766531 $ANIP

User Image tickeron Posted - 5 days ago

What do you think of this? $ANIP RSI Indicator left the oversold zone. View odds of downtrend. https://srnk.us/go/4929812

User Image Dy2ski Posted - 11/29/23

$ANIP Very good presentation at Piper Conference. Appreciate the line of questions and CEO Lalwani's answers and color on the business. Pretty helpful after a floundering through the Earnings Call Such a disappointment, though that the market is clearly rallying into the EOY but $ANIP has lost all momentum, a ton of value and missing the run. So far, anyway. 🤦

User Image tickeron Posted - 11/27/23

Don't miss this opportunity! $ANIP in Uptrend: price may jump up because it broke its lower Bollinger Band on November 8, 2023. View odds for this and other indicators: https://srnk.us/go/4925929

User Image xbizo Posted - 11/22/23

$ANIP Guess they need money for black Friday

User Image stockilluminati Posted - 11/22/23

$ANIP https://www.stockilluminati.com/anip/news.php - ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

User Image Stock_Titan Posted - 11/22/23

$ANIP ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference https://www.stocktitan.net/news/ANIP/ani-pharmaceuticals-to-present-at-the-piper-sandler-35th-annual-92r06dcvvmrc.html

User Image insiderbuyingselling Posted - 11/20/23

$ANIP new insider selling: 13000 shares. http://insiderbuyingselling.com/?t=ANIP

User Image cctranscripts Posted - 11/20/23

HEAD OF R&D of ANI Pharmaceuticals just disposed of 13,000 shares https://www.conferencecalltranscripts.org/summary/?id=12725658 $ANIP

User Image risenhoover Posted - 11/20/23

Insider Muthusamy Shanmugam reports selling 13,000 shares of $ANIP for a total cost of $663,000.00 https://fintel.io/n/us/anip/shanmugam-muthusamy?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 11/20/23

HEAD OF R&D of ANI Pharmaceuticals just disposed of 37,000 shares https://www.conferencecalltranscripts.org/summary/?id=12725648 $ANIP

User Image EarningsInsider Posted - 11/17/23

ANI Pharmaceuticals, Inc. Files SEC Form 144 $ANIP https://www.marketbeat.com/stocks/NASDAQ/ANIP/sec-filings/

User Image cctranscripts Posted - 11/17/23

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12719640 $ANIP

User Image InsiderPeek Posted - 11/17/23

$ANIP Chief Hr Officer Davis Krista sold 2.6k shares for $141.1k (ownership down 7.45%) insiderpeek.com/company/ANIP

User Image MarkItUpABuck Posted - 11/17/23

$ANIP Incredible how this company always finds a way to stick it to shareholders.

User Image insiderbuyingselling Posted - 11/17/23

$ANIP new insider selling: 2622 shares. http://insiderbuyingselling.com/?t=ANIP

User Image MarketBeatInsiderTrades Posted - 11/16/23

ANI Pharmaceuticals COO Muthusamy Shanmugam Sells $333,103.68 in $ANIP www.marketbeat.com/stocks/NASDAQ/ANIP/insider-trades/

User Image MarketBeatInsiderTrades Posted - 11/16/23

ANI Pharmaceuticals COO Muthusamy Shanmugam Sells $1,174,791.15 in $ANIP www.marketbeat.com/stocks/NASDAQ/ANIP/insider-trades/

User Image MarketBeatInsiderTrades Posted - 11/16/23

ANI Pharmaceuticals SVP Krista Davis Sells $141,089.82 in $ANIP www.marketbeat.com/stocks/NASDAQ/ANIP/insider-trades/

User Image MarkItUpABuck Posted - 11/16/23

$ANIP Muthusamy Shanmugam is not letting up and he still owns a ton more. Can’t even blame him. Ani board should never have put that much stock in his hand without better controls on it.

User Image MarkItUpABuck Posted - 11/16/23

$ANIP - NOVITIUM executives still selling down here. Pricks.

User Image cctranscripts Posted - 11/16/23

SVP of ANI Pharmaceuticals just disposed of 2,622 shares https://www.conferencecalltranscripts.org/summary/?id=12717042 $ANIP

User Image risenhoover Posted - 11/16/23

Insider Krista Davis reports selling 2,622 shares of $ANIP for a total cost of $141,089.82 https://fintel.io/n/us/anip/davis-krista?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image cctranscripts Posted - 11/16/23

HEAD OF R&D of ANI Pharmaceuticals just disposed of 36,190 shares https://www.conferencecalltranscripts.org/summary/?id=12717036 $ANIP

User Image risenhoover Posted - 11/16/23

Insider Muthusamy Shanmugam reports selling 36,190 shares of $ANIP for a total cost of $1,918,079.91 https://fintel.io/n/us/anip/shanmugam-muthusamy?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image EarningsInsider Posted - 11/16/23

ANI Pharmaceuticals, Inc. Files SEC Form 144 $ANIP https://www.marketbeat.com/stocks/NASDAQ/ANIP/sec-filings/

User Image cctranscripts Posted - 11/16/23

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12716763 $ANIP

User Image Dy2ski Posted - 11/15/23

$ANIP And right on cue, Insiders still dumping shares. Apparently, Novitium Founders prefer selling more than holding $ANIP shares. Lovely. Great deal for them considering they had absolutely nothing to do with Cortrophin which is what is providing the only real growth and comfort for the company and it was purchased by the former CEO 7 years or so ago!

User Image cctranscripts Posted - 11/15/23

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12712892 $ANIP

User Image EarningsInsider Posted - 11/15/23

ANI Pharmaceuticals, Inc. Files SEC Form 144 $ANIP https://www.marketbeat.com/stocks/NASDAQ/ANIP/sec-filings/

Analyst Ratings
Guggenheim Buy Oct 19, 23
Guggenheim Buy Sep 13, 23
HC Wainwright & Co. Buy Aug 22, 23
Truist Securities Buy Aug 21, 23
Guggenheim Buy Aug 10, 23
Guggenheim Buy Jul 27, 23
Truist Securities Buy Jul 21, 23
Guggenheim Buy May 9, 23
Truist Securities Buy May 9, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Shanmugam Muthusamy HEAD OF R&D, COO-NOV.. HEAD OF R&D, COO-NOVITIUM OPS Nov 17 Sell 51 13,000 663,000 982,620 11/20/23
Shanmugam Muthusamy HEAD OF R&D, COO-NOV.. HEAD OF R&D, COO-NOVITIUM OPS Nov 14 Sell 52.82 37,000 1,954,340 995,620 11/20/23
Davis Krista SVP, CHIEF HR OFFICE.. SVP, CHIEF HR OFFICER Nov 15 Sell 53.81 2,622 141,090 32,587 11/16/23
Gassert Chad SVP - CORP. DEV. & S.. SVP - CORP. DEV. & STRATEGY Oct 02 Sell 56.48 20,000 1,129,600 293,226 10/03/23
Shanmugam Muthusamy HEAD OF R&D, COO-NOV.. HEAD OF R&D, COO-NOVITIUM OPS Sep 15 Sell 61.89 50,000 3,094,500 1,082,620 09/19/23
Gassert Chad SVP - CORP. DEV. & S.. SVP - CORP. DEV. & STRATEGY Sep 01 Sell 64.70 20,000 1,294,000 313,226 09/05/23
MERIDIAN VENTURE PARTNERS II L... 10% Owner 10% Owner Aug 16 Sell 58.50 200,000 11,700,000 1,819,259 08/16/23
Shanmugam Muthusamy HEAD OF R&D, COO-NOV.. HEAD OF R&D, COO-NOVITIUM OPS Aug 14 Sell 61.38 50,000 3,069,000 1,182,620 08/16/23
Pera Antonio R Director Director Aug 14 Sell 60.37 3,000 181,110 33,627 08/15/23
Lalwani Nikhil PRESIDENT & CEO PRESIDENT & CEO Aug 11 Option 29 11,616 336,864 365,006 08/15/23
Lalwani Nikhil PRESIDENT & CEO PRESIDENT & CEO Aug 11 Sell 59.44 68,282 4,058,682 353,390 08/15/23
Gassert Chad SVP - CORP. DEV. & S.. SVP - CORP. DEV. & STRATEGY Aug 01 Sell 51.06 20,000 1,021,200 333,226 08/03/23
Shanmugam Muthusamy HEAD OF R&D, COO-NOV.. HEAD OF R&D, COO-NOVITIUM OPS Jul 19 Sell 51.85 23,469 1,216,868 1,232,620 07/21/23
Shanmugam Muthusamy HEAD OF R&D, COO-NOV.. HEAD OF R&D, COO-NOVITIUM OPS Jul 14 Sell 51.11 26,531 1,355,999 1,256,089 07/18/23
Shanmugam Muthusamy HEAD OF R&D, COO-NOV.. HEAD OF R&D, COO-NOVITIUM OPS Jun 20 Sell 51.69 50,000 2,584,500 1,282,620 06/23/23
Gassert Chad SVP - CORP. DEV. & S.. SVP - CORP. DEV. & STRATEGY Jun 22 Sell 51.32 20,000 1,026,400 373,226 06/23/23
Marken James G. SVP OPS & PROD DEV SVP OPS & PROD DEV Aug 12 Sell 37.42 18,066 676,030 117,642 08/16/22
Lalwani Nikhil PRESIDENT & CEO PRESIDENT & CEO Mar 21 Buy 27.6851 7,224 199,997 169,650 03/23/22
Walsh Patrick D Director Director Mar 21 Buy 27.7588 5,000 138,794 53,388 03/22/22
Gassert Chad SVP - CORP. DEV. & S.. SVP - CORP. DEV. & STRATEGY Mar 18 Buy 27.51 10,000 275,100 393,226 03/22/22
Shanmugam Muthusamy HEAD OF R&D, COO-NOV.. HEAD OF R&D, COO-NOVITIUM OPS Mar 17 Buy 27.65 10,000 276,500 5,000 03/21/22